CELC.NASDAQCelcuity INC

Form 4: Celcuity CEO Exercises Warrants, Boosts Stock Holdings

Sentiment:

Insider Transaction Report


Celcuity Inc.'s CEO, Brian F. Sullivan, acquired 104,340 shares of common stock through warrant exercise at $8.05 per share.

Summary

  • Brian F. Sullivan, Celcuity Inc.'s Director and Chief Executive Officer, acquired 104,340 shares of common stock.
  • The acquisition occurred on September 2, 2025, through the exercise of derivative securities (warrants).
  • The exercise price for the common stock was $8.05 per share.
  • Following this transaction, Mr. Sullivan directly beneficially owns 1,370,199 shares of common stock.
  • Additionally, Mr. Sullivan indirectly beneficially owns 948,042 shares through Family Trust #1 and 802,742 shares through Family Trust #2, totaling 1,750,784 indirect shares.
  • The warrants, which allowed the right to buy common stock at $8.05, were exercisable from December 9, 2022, and are set to expire on October 11, 2025.
  • Mr. Sullivan holds all voting and dispositive power over the securities held by the family trusts.

Sentiment

Score: 7

Explanation: The CEO's exercise of warrants to increase his direct stock ownership is generally viewed as a positive signal of confidence in the company's future prospects.

Positives

  • The Chief Executive Officer's decision to exercise warrants and increase his direct ownership stake signals strong confidence in Celcuity Inc.'s future performance.
  • Increased insider ownership aligns management's interests more closely with those of shareholders.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

  • Brian F. Sullivan holds all voting and dispositive power with respect to the securities held by the family trusts and is the beneficial owner of these securities.

Industry Context

This insider transaction is a company-specific event and does not directly reflect broader industry trends. However, insider buying can be a positive signal within the biotechnology or pharmaceutical sector, indicating management's belief in upcoming milestones or product success.

Related Party Transactions

  • Indirect beneficial ownership through Family Trust #1 and Family Trust #2, where the reporting person holds all voting and dispositive power.

Stakeholder Impact

  • Shareholders may interpret the CEO's increased stake as a positive indicator of management's belief in the company's value and future growth, potentially boosting investor confidence.

Key Dates

DateDescription
12/09/2022Date warrants became exercisable.
09/02/2025Transaction date for warrant exercise and common stock acquisition.
09/04/2025Date the Form 4 filing was signed.
10/11/2025Expiration date of the warrants.

Recommendation

buy

The CEO's decision to exercise warrants and increase his direct ownership at a specific price suggests confidence in the company's future prospects. This insider buying can be a positive signal for investors, indicating management's belief in the company's intrinsic value, though it should be considered alongside broader financial analysis.

Keywords

Celcuity, CELC, Form 4, Insider Trading, Stock Acquisition, Warrants, CEO, Brian F. Sullivan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.